220 related articles for article (PubMed ID: 22207681)
1. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?
Tang G; Zuo Z; Thomas DA; Lin P; Liu D; Hu Y; Kantarjian HM; Bueso-Ramos C; Medeiros LJ; Wang SA
Haematologica; 2012 Jun; 97(6):919-25. PubMed ID: 22207681
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
3. Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to
Aldoss I; Stiller T; Tsai NC; Song JY; Cao T; Bandara NA; Salhotra A; Khaled S; Aribi A; Al Malki MM; Mei M; Ali H; Spielberger R; O'Donnell M; Snyder D; Slavin T; Nakamura R; Stein AS; Forman SJ; Marcucci G; Pullarkat V
Haematologica; 2018 Oct; 103(10):1662-1668. PubMed ID: 29903756
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89.
Ludwig WD; Rieder H; Bartram CR; Heinze B; Schwartz S; Gassmann W; Löffler H; Hossfeld D; Heil G; Handt S; Heyll A; Diedrich H; Fischer K; Weiss A; Völkers B; Aydemir U; Fonatsch C; Gökbuget N; Thiel E; Hoelzer D
Blood; 1998 Sep; 92(6):1898-909. PubMed ID: 9731046
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related acute lymphoblastic leukemia is a distinct entity with adverse genetic features and clinical outcomes.
Saygin C; Kishtagari A; Cassaday RD; Reizine N; Yurkiewicz I; Liedtke M; Stock W; Larson RA; Levine RL; Tallman MS; Park JH; Kerr C; Przychodzen B; Sekeres MA; Kalaycio ME; Carraway HE; Hamilton BK; Sobecks R; Gerds A; Mukherjee S; Nazha A; Maciejewski JP; Advani AS
Blood Adv; 2019 Dec; 3(24):4228-4237. PubMed ID: 31869410
[TBL] [Abstract][Full Text] [Related]
6. Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.
Lafage-Pochitaloff M; Baranger L; Hunault M; Cuccuini W; Lefebvre C; Bidet A; Tigaud I; Eclache V; Delabesse E; Bilhou-Nabéra C; Terré C; Chapiro E; Gachard N; Mozziconacci MJ; Ameye G; Porter S; Grardel N; Béné MC; Chalandon Y; Graux C; Huguet F; Lhéritier V; Ifrah N; Dombret H;
Blood; 2017 Oct; 130(16):1832-1844. PubMed ID: 28790105
[TBL] [Abstract][Full Text] [Related]
7. High frequency of pro-B acute lymphoblastic leukemia in adults with secondary leukemia with 11q23 abnormalities.
Ishizawa S; Slovak ML; Popplewell L; Bedell V; Wrede JE; Carter NH; Snyder DS; Arber DA
Leukemia; 2003 Jun; 17(6):1091-5. PubMed ID: 12764373
[TBL] [Abstract][Full Text] [Related]
8. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.
Seiter K; Feldman EJ; Sreekantaiah C; Pozzuoli M; Weisberger J; Liu D; Papageorgio C; Weiss M; Kancherla R; Ahmed T
Leukemia; 2001 Jun; 15(6):963-70. PubMed ID: 11417484
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens.
Jain P; Gu J; Kanagal-Shamanna R; Tang Z; Patel KP; Yao H; Fang L; Bao HY; Liu CH; Lin P; Medeiros LJ; Lu X
Leuk Res; 2019 Sep; 84():106176. PubMed ID: 31279181
[TBL] [Abstract][Full Text] [Related]
10. Frequency of chromosomal abnormalities in Pakistani adults with acute lymphoblastic leukemia.
Shaikh MS; Adil SN; Shaikh MU; Khurshid M
Asian Pac J Cancer Prev; 2014; 15(21):9495-8. PubMed ID: 25422245
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.
Gómez-Seguí I; Cervera J; Such E; Martínez-Cuadrón D; Luna I; Ibáñez M; López-Pavía M; Gascón A; Roig M; Martínez J; Sanz J; Montesinos P; Martín-Aragonés G; Lorenzo I; Senent L; Barragán E; Cordón L; Sempere A; Sanz GF; Sanz MA
Ann Hematol; 2012 Jan; 91(1):19-25. PubMed ID: 21935650
[TBL] [Abstract][Full Text] [Related]
12. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis.
Liu W; Hu S; Konopleva M; Khoury JD; Kalhor N; Tang G; Bueso-Ramos CE; Jorgensen JL; Lin P; Medeiros LJ; Lu X
Pediatr Hematol Oncol; 2015; 32(8):535-47. PubMed ID: 26558423
[TBL] [Abstract][Full Text] [Related]
13. Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A Collaborative Study of the Group Français de Cytogénétique Hématologique.
Blood; 1996 Apr; 87(8):3135-42. PubMed ID: 8605327
[TBL] [Abstract][Full Text] [Related]
14. Secondary acute lymphoblastic leukemia is an independent predictor of poor prognosis.
Giri S; Chi M; Johnson B; McCormick D; Jamy O; Bhatt VR; Martin MG
Leuk Res; 2015 Dec; 39(12):1342-6. PubMed ID: 26427729
[TBL] [Abstract][Full Text] [Related]
15. Twenty-three cases of acute lymphoblastic leukemia with translocation t(4;11)(q21;q23): the implication of additional chromosomal aberrations.
Schoch C; Rieder H; Freund M; Hoelzer D; Riehm H; Fonatsch C
Ann Hematol; 1995 Apr; 70(4):195-201. PubMed ID: 7748964
[TBL] [Abstract][Full Text] [Related]
16. Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Mauritzson N; Albin M; Rylander L; Billström R; Ahlgren T; Mikoczy Z; Björk J; Strömberg U; Nilsson PG; Mitelman F; Hagmar L; Johansson B
Leukemia; 2002 Dec; 16(12):2366-78. PubMed ID: 12454741
[TBL] [Abstract][Full Text] [Related]
17. B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review.
Sinit RB; Hwang DG; Vishnu P; Peterson JF; Aboulafia DM
BMC Cancer; 2019 Nov; 19(1):1147. PubMed ID: 31775673
[TBL] [Abstract][Full Text] [Related]
18. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
19. Four cases of therapy-related leukemia.
Hur M; Lee DS; Shin HY; Ahn HS; Kim BK; Cho HI
J Korean Med Sci; 1999 Jun; 14(3):327-9. PubMed ID: 10402178
[TBL] [Abstract][Full Text] [Related]
20. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
Topp MS; Gökbuget N; Stein AS; Zugmaier G; O'Brien S; Bargou RC; Dombret H; Fielding AK; Heffner L; Larson RA; Neumann S; Foà R; Litzow M; Ribera JM; Rambaldi A; Schiller G; Brüggemann M; Horst HA; Holland C; Jia C; Maniar T; Huber B; Nagorsen D; Forman SJ; Kantarjian HM
Lancet Oncol; 2015 Jan; 16(1):57-66. PubMed ID: 25524800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
